Newsroom
Strive to Deliver Breakthroughs
Harbour, Mount Sinai partner to develop Mabs targeting cancer, immunology and coronavirus
View moreHarbour BioMed nabs meaty C round as cancer, COVID-19 work draws investors
View moreHarbour BioMed Raises $102.8M in Series C Financing
View moreChina's Harbour BioMed rakes in $102.7m to speed up COVID-19 pipeline
View moreAnother biotech IPO set-up? Multinational biotech leaps from round to round, scooping up cash at a blistering pace
View moreHarbour BioMed Closes $103 Million Financing for Biologic Portfolio
View moreHarbour BioMed Raises $102.8M in Series C Financing to Accelerate Development of Its Innovative Portfolio of Next Generation Biologics
View moreHarbour BioMed Raises $102 Million to Support Development Programs
View moreAbbVie, Harbour BioMed to develop Ab therapy for COVID-19
View moreBRIEF-Abbvie, Harbour Biomed, Utrecht University And Erasmus Medical Center Collaborate To Develop Covid-19 Antibody Therapy
View more